Skip to content
BLACK BOOK
manufacturer✓ Verified☎ Contact on file

Trevi Therapeutics, Inc.

Pharmaceutical Preparations · New Haven, CT, United States

  1. PrincipalsDavid C HastingsChief Financial OfficerFarrell SimonChief Commercial OfficerJames V CassellaChief Development Officerand 3 more
  2. CompanyTrevi Therapeutics, Inc.New Haven, CT, United States
  3. Phone line+1 (203) 304-2499General business
Request a quote

Trevi Therapeutics, Inc. is an SEC-registered Nasdaq-listed company (ticker TRVI) classified under SIC 2834: Pharmaceutical Preparations.

Capabilities

✓ Pharmaceutical manufacturing
Evidence for each capability
  • Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions

People 6

Chief executive

Jennifer L GoodPresident & CEO

Finance

David C HastingsChief Financial Officer

Sales & commercial

Farrell SimonChief Commercial Officer
Everyone else on file (3)
James V CassellaChief Development Officer
Thomas SciasciaChief Scientific Officer
Christopher GallettaOfficer (see SEC filing)

Supplier profile

Production
Yes

Source timeline

  1. Record created from SEC EDGAR company submissions

    SEC EDGAR company submissions ↗
  2. Farrell Simon — Chief Commercial Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  3. James V Cassella — Chief Development Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  4. Jennifer L Good — President & CEO

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  5. David C Hastings — Chief Financial Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗

Similar makers